DE602005013822D1 - Cycloalkylaminderivate - Google Patents
CycloalkylaminderivateInfo
- Publication number
- DE602005013822D1 DE602005013822D1 DE602005013822T DE602005013822T DE602005013822D1 DE 602005013822 D1 DE602005013822 D1 DE 602005013822D1 DE 602005013822 T DE602005013822 T DE 602005013822T DE 602005013822 T DE602005013822 T DE 602005013822T DE 602005013822 D1 DE602005013822 D1 DE 602005013822D1
- Authority
- DE
- Germany
- Prior art keywords
- sup
- compounds
- cycloalkylaminderivate
- dpp
- prophylaxis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04106704 | 2004-12-20 | ||
PCT/EP2005/013433 WO2006066770A1 (en) | 2004-12-20 | 2005-12-14 | Cycloalkylamine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005013822D1 true DE602005013822D1 (de) | 2009-05-20 |
Family
ID=35986018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005013822T Active DE602005013822D1 (de) | 2004-12-20 | 2005-12-14 | Cycloalkylaminderivate |
Country Status (14)
Country | Link |
---|---|
US (1) | US7411093B2 (de) |
EP (1) | EP1833782B1 (de) |
JP (1) | JP4666533B2 (de) |
KR (1) | KR100898156B1 (de) |
CN (1) | CN101084184A (de) |
AT (1) | ATE427926T1 (de) |
AU (1) | AU2005318530A1 (de) |
BR (1) | BRPI0519106A2 (de) |
CA (1) | CA2590985A1 (de) |
DE (1) | DE602005013822D1 (de) |
ES (1) | ES2321859T3 (de) |
MX (1) | MX2007007174A (de) |
RU (1) | RU2402526C2 (de) |
WO (1) | WO2006066770A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006009886A1 (en) * | 2004-06-21 | 2006-01-26 | Merck & Co., Inc. | Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
ATE473742T1 (de) | 2004-08-23 | 2010-07-15 | Merck Sharp & Dohme | Kondensierte triazolderivate als dipeptidylpeptidase-iv-hemmer zur behandlung bzw. prävention von diabetes |
JP4797021B2 (ja) * | 2004-10-01 | 2011-10-19 | メルク・シャープ・エンド・ドーム・コーポレイション | 糖尿病の治療または予防用のジペプチジルペプチダ−ゼ−iv阻害剤としてのアミノピペリジン |
US7411093B2 (en) * | 2004-12-20 | 2008-08-12 | Hoffman-La Roche Inc. | Aminocycloalkanes as DPP-IV inhibitors |
DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
BRPI0615102A2 (pt) * | 2005-08-30 | 2011-05-03 | Abbott Lab | composto, composições farmacêuticas como inibidores de dipeptidil peptidase-iv (dpp-iv), bem como uso |
DK1971862T3 (da) | 2006-04-11 | 2011-02-14 | Arena Pharm Inc | Fremgangsmåder til anvendelse af GPR119-receptor til identificering af forbindelser anvendelige til øgning af knoglemasse hos en person |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
WO2007148185A2 (en) * | 2006-06-21 | 2007-12-27 | Pfizer Products Inc. | Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体 |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
EP2617704B1 (de) * | 2007-05-31 | 2017-06-28 | Sunovion Pharmaceuticals Inc. | Phenyl-substituierte Cycloalkylamine als Monoamin-Wiederaufnahmehemmer |
EP2108960A1 (de) * | 2008-04-07 | 2009-10-14 | Arena Pharmaceuticals, Inc. | Verfahren zur Verwendung eines A G Protein-gekoppelten Rezeptors zur Identifikation von Peptid YY (PYY) Sekretagoga und nützliche Verbindungen zur Behandlung von durch (PYY) Sekretagoga modulierten Zuständen und nützliche Verbindungen zur Behandlung von Zuständen durch PYY |
JO2870B1 (en) | 2008-11-13 | 2015-03-15 | ميرك شارب اند دوهم كورب | Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes |
WO2011028455A1 (en) | 2009-09-02 | 2011-03-10 | Merck Sharp & Dohme Corp. | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
JP5934645B2 (ja) | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
US8716482B2 (en) | 2009-09-25 | 2014-05-06 | Merck Sharp & Dohme Corp. | Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
CN102791704B (zh) | 2010-03-10 | 2015-11-25 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶(qc, ec 2.3.2.5)的杂环抑制剂 |
EP2560953B1 (de) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Hemmer der glutaminylzyklase |
JP6050264B2 (ja) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
EP2731923B1 (de) * | 2011-07-12 | 2015-09-09 | Basf Se | Verfahren zur herstellung von cyclohepten |
WO2016144862A1 (en) | 2015-03-09 | 2016-09-15 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
EP3606527A1 (de) | 2017-04-03 | 2020-02-12 | Coherus Biosciences, Inc. | Ppar-gamma-agonist zur behandlung der progressiven supranuklearen blickparese |
DK3461819T3 (da) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | Inhibitorer af glutaminylcyklase |
US11091426B1 (en) | 2020-05-05 | 2021-08-17 | United Arab Emirates University | Cycloheptylamine derivatives as anti-diabetic agents |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670235A1 (de) | 1967-06-08 | 1971-01-28 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von Adenosin-Derivaten |
US4061746A (en) * | 1976-04-23 | 1977-12-06 | Richardson-Merrell Inc. | Lactamimide inhibitors of gastrointestinal hypersecretion |
DE69112201T2 (de) | 1990-02-02 | 1996-02-15 | Schering Corp | 4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung. |
JP4138003B2 (ja) * | 1996-01-31 | 2008-08-20 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のフェナントリジン |
DE122010000020I1 (de) * | 1996-04-25 | 2010-07-08 | Prosidion Ltd | Verfahren zur Senkung des Blutglukosespiegels in Säugern |
US20020006899A1 (en) * | 1998-10-06 | 2002-01-17 | Pospisilik Andrew J. | Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals |
US6011155A (en) * | 1996-11-07 | 2000-01-04 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
WO1999038501A2 (en) | 1998-02-02 | 1999-08-05 | Trustees Of Tufts College | Method of regulating glucose metabolism, and reagents related thereto |
DE19834591A1 (de) * | 1998-07-31 | 2000-02-03 | Probiodrug Ges Fuer Arzneim | Verfahren zur Steigerung des Blutglukosespiegels in Säugern |
CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
NZ512872A (en) * | 1999-01-15 | 2003-07-25 | Altana Pharma Ag | Phenylphenanthridines with PDE-IV inhibiting activity |
US6110949A (en) * | 1999-06-24 | 2000-08-29 | Novartis Ag | N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
GB9928330D0 (en) | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
ES2307537T3 (es) | 1999-12-08 | 2008-12-01 | Eli Lilly And Company | Derivados de ciclopentil sulfonamida. |
AU2001228309A1 (en) | 2000-01-24 | 2001-08-07 | Novo-Nordisk A/S | N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
PE20050130A1 (es) * | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
RS20050116A (en) * | 2002-08-17 | 2007-11-15 | Altana Pharma Ag., | Novel phenanthridines |
US7411093B2 (en) * | 2004-12-20 | 2008-08-12 | Hoffman-La Roche Inc. | Aminocycloalkanes as DPP-IV inhibitors |
-
2005
- 2005-12-13 US US11/302,067 patent/US7411093B2/en not_active Expired - Fee Related
- 2005-12-14 WO PCT/EP2005/013433 patent/WO2006066770A1/en active Application Filing
- 2005-12-14 AU AU2005318530A patent/AU2005318530A1/en not_active Abandoned
- 2005-12-14 EP EP05817968A patent/EP1833782B1/de not_active Not-in-force
- 2005-12-14 DE DE602005013822T patent/DE602005013822D1/de active Active
- 2005-12-14 ES ES05817968T patent/ES2321859T3/es active Active
- 2005-12-14 JP JP2007547276A patent/JP4666533B2/ja not_active Expired - Fee Related
- 2005-12-14 BR BRPI0519106-8A patent/BRPI0519106A2/pt not_active IP Right Cessation
- 2005-12-14 CA CA002590985A patent/CA2590985A1/en not_active Abandoned
- 2005-12-14 KR KR1020077016599A patent/KR100898156B1/ko not_active IP Right Cessation
- 2005-12-14 CN CNA2005800436236A patent/CN101084184A/zh active Pending
- 2005-12-14 AT AT05817968T patent/ATE427926T1/de active
- 2005-12-14 MX MX2007007174A patent/MX2007007174A/es active IP Right Grant
- 2005-12-14 RU RU2007127643/04A patent/RU2402526C2/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2007127643A (ru) | 2009-01-27 |
EP1833782A1 (de) | 2007-09-19 |
ATE427926T1 (de) | 2009-04-15 |
WO2006066770A1 (en) | 2006-06-29 |
BRPI0519106A2 (pt) | 2008-12-23 |
KR20070087172A (ko) | 2007-08-27 |
RU2402526C2 (ru) | 2010-10-27 |
US7411093B2 (en) | 2008-08-12 |
ES2321859T3 (es) | 2009-06-12 |
MX2007007174A (es) | 2007-08-14 |
KR100898156B1 (ko) | 2009-05-19 |
CN101084184A (zh) | 2007-12-05 |
AU2005318530A1 (en) | 2006-06-29 |
JP2008524279A (ja) | 2008-07-10 |
US20060135512A1 (en) | 2006-06-22 |
CA2590985A1 (en) | 2006-06-29 |
EP1833782B1 (de) | 2009-04-08 |
JP4666533B2 (ja) | 2011-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005013822D1 (de) | Cycloalkylaminderivate | |
TW200504063A (en) | DPP-IV inhibitors | |
TW200505919A (en) | DPP-IV inhibitors | |
TW200631580A (en) | Substituted benzoquinolizine derivatives | |
CA2474578A1 (en) | Novel pyridin- and pyrimidin-derivatives | |
WO2006066747A8 (en) | 4-aminopiperidine derivatives | |
MXPA04003759A (es) | Derivados de pirrolidin n-substituido como inhibidores de dipeptidil peptidasa iv. | |
MY141972A (en) | Biaryloxymethylarenecarboxylic acids | |
TWI265163B (en) | Novel pyrido[2,1-a]isoquinoline derivatives | |
JO2282B1 (en) | Oxazole derivatives | |
DE602006009095D1 (en) | Diacylglycerol-acyltransferase-hemmer | |
MX2007006397A (es) | Derivados de tetrahidropirano. | |
NO20065260L (no) | Tri(cyklo)substituerte amidforbindelser | |
UA92355C2 (en) | urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS | |
NO20056010L (no) | Biaryloksymetylaren-karboksylsyrer | |
NO20082496L (no) | Pyrazinderivater | |
SE0403006D0 (sv) | New compounds | |
ATE384058T1 (de) | Thiazolderivate | |
HK1138265A1 (en) | Materials and methods for treating coagulation disorders | |
ATE553077T1 (de) | Peptidaseinhibitoren | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
DE602004018630D1 (en) | Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten | |
TW200609228A (en) | Substituted n-acyl-2-aminothiazoles | |
TW200800960A (en) | Novel 2,3-dihydroindole compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |